We are live on ! Find out more
IMNM icon

Immunome
IMNM

113 hedge funds and large institutions have $578M invested in Immunome in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

73% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 22

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

36% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $882K

13.67% more ownership

Funds ownership: 66% → 79.67% (+14%)

9% more funds holding

Funds holding: 104 → 113 (+9)

36% less capital invested

Capital invested by funds: $907M → $578M (-$329M)

Holders
113
Holders Change
+9
Holders Change %
+8.65%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
39
Increased
38
Reduced
22
Closed
28
Calls
$1.2M
Puts
$882K
Net Calls
+$317K
Net Calls Change
-$579K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$45.8M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$37M
3
State Street
State Street
Massachusetts
+$33.8M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$25.4M
5
Marshall Wace
Marshall Wace
United Kingdom
+$18.6M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.7M
2
FCM
Farallon Capital Management
California
-$14.7M
3
Millennium Management
Millennium Management
New York
-$11.5M
4
Invesco
Invesco
Georgia
-$9.37M
5
WP
Woodline Partners
California
-$6.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$3.62M +$4.68M +299,290 New
Primecap Management
27
Primecap Management
California
$3.25M +$873K +55,800 +26%
Ameriprise
28
Ameriprise
Minnesota
$3.06M -$171K -10,957 -4%
Bank of America
29
Bank of America
North Carolina
$2.9M +$3.6M +230,215 +2,458%
Handelsbanken Fonder
30
Handelsbanken Fonder
Sweden
$2.78M +$704K +45,000 +24%
Adage Capital Partners
31
Adage Capital Partners
Massachusetts
$2.66M +$3.44M +220,000 New
Goldman Sachs
32
Goldman Sachs
New York
$2.23M -$2.31M -147,516 -44%
Axa
33
Axa
France
$2.17M +$2.81M +179,688 New
Northern Trust
34
Northern Trust
Illinois
$2.06M +$544K +34,761 +26%
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.02M +$895K +57,242 +52%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$1.82M +$2.35M +150,100 New
Charles Schwab
37
Charles Schwab
California
$1.69M +$1.9M +121,585 +676%
JF
38
Jump Financial
Illinois
$1.63M +$2.1M +134,300 New
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.4M +$1.82M +116,045 New
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$1.38M +$1.78M +113,934 New
Two Sigma Investments
41
Two Sigma Investments
New York
$1.3M +$1.69M +107,846 New
HA
42
HHLR Advisors
Cayman Islands
$1.3M +$1.68M +107,626 New
Renaissance Technologies
43
Renaissance Technologies
New York
$1.13M +$747K +47,782 +105%
SG Americas Securities
44
SG Americas Securities
New York
$1.09M +$1.42M +90,504 New
UBS Group
45
UBS Group
Switzerland
$940K +$830K +53,032 +215%
Swiss National Bank
46
Swiss National Bank
Switzerland
$924K +$78.2K +5,000 +7%
ZP
47
Zimmer Partners
New York
$908K – – –
ACM
48
Atika Capital Management
New York
$895K -$3.77M -241,000 -77%
Squarepoint
49
Squarepoint
New York
$895K -$717K -45,843 -38%
NFC
50
Northeast Financial Consultants
Connecticut
$883K +$1.14M +72,953 New
1
2
3 4 5

IMNM Hedge Fund Activity: Q2 2024 in Review

113 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q2 2024, worth a combined $578M — down 36% from $907M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IMNM positions and 28 closed out — a net gain of 11 holders — while 38 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $45.8M. The largest seller was Point72 Asset Management, cutting an estimated $19.7M.

  • 113 institutional investors held Immunome (IMNM) as of Q2 2024, up from 104 in Q1 2024.
  • Funds reported $578M of Immunome stock for Q2 2024, down 36% quarter-over-quarter.
  • 39 funds opened new Immunome positions in Q2 2024 and 28 closed out, a net change of +11 holders.
  • The largest Immunome buyer in Q2 2024 was BlackRock, an estimated $45.8M added.
  • The largest Immunome seller in Q2 2024 was Point72 Asset Management, an estimated $19.7M sold.

Based on aggregated 13F filings for Q2 2024.